The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Dermata Therapeutics has announced positive results from a Phase 1 POC clinical trial of DMT410 (DMT310 + botulinum toxin (BTX)) for the treatment of ...
read more
American Regent has announced the introduction of Selenious Acid Injection, USP.
read more
Seqirus announced it is first-to-market with shipping its portfolio of seasonal influenza vaccines to customers in the United States for the 2019/20 ...
read more
Janssen Research & Development
Janssen Biotech has submitted a BLA to the FDA for the subcutaneous delivery of DARZALEX® (daratumumab) for patients with multiple myeloma.
read more
Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Fulvestrant ...
read more
As part of its broader efforts to reign in health care prices that place a tremendous financial burden on families throughout the state, Blue Cross ...
read more
Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) has approved Taltz® (ixekizumab) injection 80 mg/mL for the treatment...
read more
Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for ...
read more
Monday, September 09, 2019
Janssen announced positive results from two pivotal studies to evaluate the efficacy and safety of SPRAVATO™ in addition to comprehensive SOC for ...
read more
Tuesday, September 10, 2019
Biohaven announced completion of enrollment in its Phase 2/3, double-blind, randomized, placebo-controlled, dose-ranging trial of intranasally ...
read more
Wednesday, September 11, 2019
The Metrix Company is recalling specific lots of the empty IV flexible containers due to potential for leaking of the IV bag at the chamber divider ...
read more
Friday, September 13, 2019
Halozyme announced the global phase III FeDeriCa study conducted by Genentech met its primary endpoint.
read more
Monday, September 16, 2019
Gala Therapeutics announced the FDA granted Breakthrough Device Designation for the RheOx Bronchial Rheoplasty system.
read more
Tuesday, September 17, 2019
Sanofi SA, Abbott Laboratories
Sanofi and Abbott are partnering to integrate glucose sensing and insulin delivery technologies that would help to further simplify how people with ...
read more
Tuesday, September 17, 2019
Takeda announced the company is issuing a US recall for all doses of NATPARA® (parathyroid hormone) for Injection (25 mcg, 50 mcg, 75 mcg, and 100 mcg...
read more